Navigation Links
How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video
Date:7/31/2014

Total Artificial Heart over left ventricle assist devices [LVADs] is the [SynCardia Total Artificial Heart] allows for high-flow biventricular support," Tang, VCU assistant professor of cardiothoracic surgery, says in the video, "as well as the ability to treat a wide range of complex cardiac pathology that may not be ideally treated with isolated [LVAD] support."

The SynCardia Total Artificial Heart is becoming the standard of care for addressing end-stage biventricular heart failure. Says Tang: "Refinements in the current generation SynCardia [Total Artificial Heart], patient selection, management of pericardial space, as well as perioperative management of the patients, have led to a marked improvement in patient outcomes."

For additional information, please visit: http://www.syncardia.com/
Like SynCardia on Facebook 
Follow SynCardia on Twitter – @SynCardia 
Connect with SynCardia on LinkedIn 
Share and Discover on Google+

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart.

Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

More than 1,300 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the devi
'/>"/>

SOURCE SynCardia Systems, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
2. The Cutting-Edge Technology of Dr. Soleymani Leads to Comfortable Dental Implants in Santa Monica
3. Arthrosurfaces Revolutionary Toe Implant Hits 9 Year Mark
4. Dental Implants & Prosthetics (Implants, Crowns & Bridges, Dentures, Abutments) Market - Current Trends, Opportunities & Global Forecasts To 2018
5. Henry Schein Completes Strategic Investment in Dental Implant Manufacturer BioHorizons
6. TorkLaw Continuing to Accept DePuy ASR Hip Implant Cases - Deadline Approaching January 6, 2014
7. Keck Medicine of USC performs worlds 1st implant after FDA approval for groundbreaking epilepsy treatment
8. FDA Clears the Provant Therapy System for Use by Patients with Metallic Implants
9. Henry Ford Hospital Implants New Defibrillator for People at Risk of Sudden Cardiac Arrest
10. SynCardia Hits Record-Setting 150th Implant of the Total Artificial Heart in 2013
11. Les implants britanniques débarquent en France
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 4, 2015 HeartWare International, Inc . ... invasive, miniaturized circulatory support technologies that are revolutionizing the ... President and Chief Executive Officer, Doug Godshall , ... Annual Growth Conference at 8:30 a.m. EDT on Thursday, ... 12-13, 2015 at the InterContinental Boston. A ...
(Date:8/4/2015)... , Aug. 4, 2015 Levi & Korsinsky ... ("Biogen" or the "Company") (NASDAQGS: BIIB) for possible violations ... and certain of its officers and/or directors have violated ... of 1934.  On Friday, July 24, 2015, prior to ... quarter 2015 financial results. Among other things, the Company ...
(Date:8/4/2015)... CARLSBAD, Calif., Aug. 4, 2015  Isis Pharmaceuticals, Inc. ... $35.6 million and $18.9 million for the three and ... a net loss of $12.1 million and $43.4 million ... financial results were driven primarily by the more than ... quarter related to the upfront payment from Bayer to ...
Breaking Medicine Technology:HeartWare Presentation At The Canaccord Genuity 35th Annual Growth Conference To Be Webcast 2SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2Isis Reports Financial Results And Highlights For Second Quarter 2015 2Isis Reports Financial Results And Highlights For Second Quarter 2015 3Isis Reports Financial Results And Highlights For Second Quarter 2015 4Isis Reports Financial Results And Highlights For Second Quarter 2015 5Isis Reports Financial Results And Highlights For Second Quarter 2015 6Isis Reports Financial Results And Highlights For Second Quarter 2015 7Isis Reports Financial Results And Highlights For Second Quarter 2015 8Isis Reports Financial Results And Highlights For Second Quarter 2015 9Isis Reports Financial Results And Highlights For Second Quarter 2015 10Isis Reports Financial Results And Highlights For Second Quarter 2015 11Isis Reports Financial Results And Highlights For Second Quarter 2015 12Isis Reports Financial Results And Highlights For Second Quarter 2015 13Isis Reports Financial Results And Highlights For Second Quarter 2015 14Isis Reports Financial Results And Highlights For Second Quarter 2015 15Isis Reports Financial Results And Highlights For Second Quarter 2015 16
... Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that ... overview at the Stifel Nicolaus Annual Healthcare Conference on Thursday, ... be held at the Four Seasons Hotel in Boston, MA. ... presentation will be available on the company,s website at ...
... (NASDAQ: STXS ) today announced that executive management ... held September 7-9, 2011 in Boston, MA.  Michael P. Kaminski, ... present an overview of the Company on Wednesday, September 7, ... webcast and subsequent archived replay of the presentation will be ...
Cached Medicine Technology:Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011 2Stereotaxis to Present at the Stifel Nicolaus Healthcare Conference on September 7, 2011 3
(Date:8/4/2015)... ... August 04, 2015 , ... ... Healthy Origins® Cognizin® is a trademark for Citicoline, a nutrient that supports ... capsule for those applications which have more of a semi-solid composition. Vegetarian ...
(Date:8/4/2015)... ... 04, 2015 , ... It’s hard to look your best, ... in Santa Barbara, CA is offering the solution by offering an underarm sweat-removing ... and odor glands in the underarms. This simple and permanent solution usually offers ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent ... have shown a rise in binge drinking among certain populations and ... depression, are continuing to examine trends and evidence to help facilitate health care ...
(Date:8/4/2015)... ... August 04, 2015 , ... They say a picture is worth ... conditions, pictures and medical art can be essential. StayWell, a health solutions company, announced ... Patient Education solutions have been used by physicians and other health care providers for ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... solutions, today announced that Bruce McCalley joins its executive leadership team as Senior ... of sales success at technology companies and expanding global markets with a special ...
Breaking Medicine News(10 mins):Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3
... time for cancer patients in Ontario for radiation has fallen, ... need//. These were the results of a study released by ... Ontario has reported that the system quality index launched last ... radiation treatment to 4.7 weeks, from seven weeks in 2002. ...
... study conducted by Dr. Martina Stippler it was found that ... brain injury//. A team at the University Of Pittsburgh Brain ... patients with severe brain injuries. The study results were presented ... Surgeons in San Francisco. ,The results show that ...
... has revealed the possibilities for the development of a ... well as reversible within a few months of discontinuing ... present are limited to condoms, vasectomy and withdrawal. ... either unreliable or as in the case of vasectomy, ...
... (FDA) has categorically ruled out endorsing the use of ... of Medicine report in 1999, which had said that ... conditions like AIDS wasting, chemotherapy induced nausea and vomiting ... statement issued on Thursday, the FDA stated that "no ...
... cancers that results in death among the Britons. This ... tablet// called Xeloda have only been given to NHS ... of Health and Clinical Excellence (NICE) issued guidance recommending ... had cancerous tissue removed at an early stage. Hence ...
... advice of central government, the Madhya Pradesh government banned ... by vets, saying that it was responsible// for 95 ... vultures are indispensable natural scavengers responsible for the disposal ... of epidemics. But when they themselves feed on animals ...
Cached Medicine News:Health News:Chemotherapy Queues in Ontario Stay Steady 2Health News:Male Contraceptives-Soon to be Reliable and Reversible 2
... Freedom leg bags are part ... a versatile line of leg bags, ... the varied needs of our customers. ... several sizes, and constructed of 100% ...
... are part of the Freedom Urinary ... leg bags, kits, and accessories designed ... our customers. These leg bags are ... of 100% latex-free soft, textured medical ...
... line of Personal Catheters® ... you would choose for ... configurations - standard, antibacterial, ... - are based on ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
Medicine Products: